HRMY supply chain intelligence for Harmony Biosciences Holdings, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CAH | Cardinal Health, Inc. | 92% | Reciprocal relationship from CAH graph: Reciprocal relationship from HRMY graph: (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manu… |
| CAH | Cardinal Health, Inc. | 92% | (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Procos, S.p.A. operates as an alternate drug substance manufa… |
| HEON-UK-LIMITED | HEON-UK-LIMITED | 92% | Heon UK Limited, a CDMO owned by Thermo Fisher Scientific Inc., manufactures our finished product tablets and fills them into unlabeled bottles. |
| INMAR-RX-SOLUTIONS-INC | INMAR-RX-SOLUTIONS-INC | 92% | Inmar Rx Solutions, Inc., an advanced technology and data analytics company, specializes in reverse distribution of our product and manages our pharmaceutical returns and product recall, if needed. |
| PHARMA-PACKAGING-SOLUTIONS-LLC-DBA-TJOAPACK-LLC | PHARMA-PACKAGING-SOLUTIONS-LLC-DBA-TJOAPACK-LLC | 92% | Pharma Packaging Solutions, LLC dba Tjoapack, LLC, handles our labeling and secondary packaging. |
| BIOPROJET | BIOPROJET | 90% | Bioprojet granted to us an exclusive license to commercialize, in the United States and its territories, commonwealths, and protectorates, including Puerto Rico, a product containing pitolisant curre… |
| CVSI | CV Sciences, Inc. | 72% | Reciprocal relationship from CVSI graph: ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condition and results of operations is depende… |
| DYN | Dyne Therapeutics, Inc. | 72% | Reciprocal relationship from DYN graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from DYN graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from DYN grap… |
| ORANY | ORANY | 72% | eting cost disclosure, drug price reporting and other transparency measures. Some states have enacted legislation creating so-called prescription drug affordability boards, which ultimately may attem… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from ORAN… |
| TMO | Thermo Fisher Scientific Inc. | 72% | Reciprocal relationship from TMO graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from TMO graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from TMO grap… |
| TMO | Thermo Fisher Scientific Inc. | 72% | (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Procos, S.p.A. operates as an alternate drug substance manufa… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ACCREDO-HEALTH-GROUP-INC | ACCREDO-HEALTH-GROUP-INC | 92% | Accredo Health Group, Inc. accounted for 34% of gross product revenue |
| PANTHERX-SPECIALTY-PHARMACY-LLC | PANTHERX-SPECIALTY-PHARMACY-LLC | 92% | PANTHERx Specialty Pharmacy LLC accounted for 27% of gross product revenue |
| CAH | Cardinal Health, Inc. | 72% | Reciprocal relationship from CAH graph: Reciprocal relationship from HRMY graph: (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manu… |
| CAH | Cardinal Health, Inc. | 72% | (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Procos, S.p.A. operates as an alternate drug substance manufa… |
| CVSI | CV Sciences, Inc. | 72% | Reciprocal relationship from CVSI graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from CVSI graph: Reciprocal relationship from HRMY graph: Reciprocal relationship from CVSI g… |
| DYN | Dyne Therapeutics, Inc. | 72% | Reciprocal relationship from DYN graph: ces and our business and operations, including clinical trials, could be disrupted by any problems with our significant third-party vendors. We engage a number… |
| ORANY | ORANY | 72% | . Various states also independently regulate controlled substances. Though state-controlled substances laws often mirror federal law, because the states are separate jurisdictions, they may separatel… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from HRMY graph: . Various states also independently regulate controlled substances. Though state-controlled substances laws often mi… |
| TMO | Thermo Fisher Scientific Inc. | 72% | Reciprocal relationship from TMO graph: Reciprocal relationship from HRMY graph: (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manu… |
| TMO | Thermo Fisher Scientific Inc. | 72% | (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Procos, S.p.A. operates as an alternate drug substance manufa… |
| EPYGENIX-THERAPEUTICS-INC | EPYGENIX-THERAPEUTICS-INC | 62% | be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or comple… |
| INMAR-RX-SOLUTIONS-INC | INMAR-RX-SOLUTIONS-INC | 62% | nôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Patheon UK Limited, a CDMO owned by Thermo Fisher Scientific Inc., manufactures our finis… |
| PATHEON-UK-LIMITED | PATHEON-UK-LIMITED | 62% | with these third parties, we may be unable to continue to successfully commercialize WAKIX and any product candidates that may receive approval. We rely and will continue to rely on certain third par… |
| PHARMA-PACKAGING-SOLUTIONS-LLC | PHARMA-PACKAGING-SOLUTIONS-LLC | 62% | nôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Patheon UK Limited, a CDMO owned by Thermo Fisher Scientific Inc., manufactures our finis… |
| TJOAPACK-LLC | TJOAPACK-LLC | 62% | nôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Patheon UK Limited, a CDMO owned by Thermo Fisher Scientific Inc., manufactures our finis… |
| ZYNERBA-PHARMACEUTICALS-INC | ZYNERBA-PHARMACEUTICALS-INC | 62% | be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or comple… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| HRMY-DEBT-10075 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2020-12-31. |
| HRMY-DEBT-10074 | Warrants outstanding: 410239 | 90% | xbrl warrant detail from xbrl 2020-12-31. |
| HRMY-DEBT | Debt stack $164.6M | 90% | Market cache reports total debt of $164.6M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| HRMY-OWNER-BLACKROCK-INC | BlackRock, Inc. | 90% | 13F overlay lists BlackRock, Inc. as top holder; 317 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| ENLT | Enlight Renewable Energy Ltd | 100.00 | 2 | |
| CHRS | Coherus Oncology, Inc. | 100.00 | 2 | |
| GEMI | Gemini Space Station, Inc. | 100.00 | 2 | |
| CANG | Cango Inc. | 100.00 | 2 | |
| BGC | BGC Group, Inc. | 100.00 | 2 | |
| CIB | Grupo Cibest S.A. | 100.00 | 2 | |
| EMMA | Emmaus Life Sciences, Inc. | 100.00 | 2 | |
| BTAI | BioXcel Therapeutics, Inc. | 100.00 | 2 | |
| BRBI | BRBI BR Partners S.A. | 100.00 | 2 | |
| CVS | CVS Health Corporation | 100.00 | 2 | |
| BLNE | Beeline Holdings, Inc. | 100.00 | 2 | |
| FENG | Phoenix New Media Limited | 100.00 | 2 | |
| RYAN | Ryan Specialty Holdings, Inc. | 100.00 | 2 | |
| CSTE | Caesarstone Ltd. | 100.00 | 2 | |
| BLSH | Bullish | 100.00 | 2 | |
| AMBR | Amber International Holding Limited | 100.00 | 2 | |
| BTDR | Bitdeer Technologies Group | 100.00 | 2 | |
| CMND | Clearmind Medicine Inc. | 100.00 | 2 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 100.00 | 2 | |
| HTGC | Hercules Capital, Inc. | 100.00 | 2 |